A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...
Murray State University’s Humanities+ Series continues on Thursday, Oct. 23 at 4 p.m. in Faculty Hall Room 208 with a ...
GLP-1–pathway agonists such as semaglutide and newer multi-agonists have transformed care for obesity and diabetes, yet developers still wrestle with durability, tissue targeting, and signal "bias." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback